Up­dat­ed: Study iden­ti­fies Covid-19 pa­tients with mu­ta­tions in­di­cat­ing remde­sivir re­sis­tance

As the bi­va­lent boost­er sea­son kicks off in earnest, a new study pub­lished yes­ter­day from NYU re­searchers iden­ti­fies two cas­es of mu­tat­ed coro­n­avirus re­sis­tant to Gilead’s remde­sivir in im­muno­com­pro­mised in­di­vid­u­als.

The two pa­tients in their 50s and 60s had both un­der­gone kid­ney trans­plants (and were both vac­ci­nat­ed pri­or to those trans­plants), with one ex­pe­ri­enc­ing Covid for sev­er­al months while re­ceiv­ing rit­ux­imab and ben­damus­tine for lym­phoma.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER